Lilly closes $1.1bn acquisition of biopharmaceutical firm Dermira
The deal expands Lilly’s portfolio of medicines with the addition of lebrikizumabfor, for atopic dermatitis and QBREXZA for…
New drug company to investigate novel multiple sclerosis treatments to halt progression of the disease
18 Feb 20Pheno Therapeutics will investigate new multiple sclerosis treatments using technology and expertise from the University of Edinburgh
Dr. Reddy’s to buy certain generics business divisions of Wockhardt for $260m
13 Feb 20Dr. Reddy’s will acquire the Wockhardt’s business divisions located in India, and few other territories of Nepal, Sri…
Azafaros secures $28m Series A funding round to further research into rare disease treatments
07 Feb 20Azafaros works in rare disease treatment, developing small-molecule drugs — commonly known as pills — to reduce the…
Catalent to acquire MaSTherCell Global for $315m
04 Feb 20The transaction is expected to be closed, subject to customary closing conditions, in the third quarter of Catalent’s…
Allergan to divest rights to Brazikumab and Zenpep
28 Jan 20The sale of brazikumab and Zenpep is expected to be closed, subject to receipt of US Federal Trade…
Clarivate Analytics to acquire Decision Resources Group for $950m
20 Jan 20Combined capabilities of Clarivate and DRG would pave ways for revenue growth through new product development and enhanced…
Biogen to acquire Pfizer’s psychiatric drug
14 Jan 20Biogen will pay an upfront payment of $75m and additional development and commercialisation milestone payments of up to…
Atrium Innovations acquires personalised nutrition platform LivingMatrix
06 Jan 20Atrium Innovations offers pharmaceutical, chemical, and nutritional products including multi-vitamins, fish oils, and antioxidants, enzymes, proteins, and herbal…
Fujifilm to acquire Hitachi’s diagnostic imaging business for $1.64bn
20 Dec 19Fujifilm intends to further expand its medical systems business by integrating its advanced image processing and AI technologies